Cambridge Healthtech Institute’s Successful Targeting of Alzheimer’s Disease meeting will meet June 5-6, 2012 in Philadelphia to address the key issues impacting current AD preclinical drug discovery. Experts from across pharma, biotech and academia will present on imaging, biomarkers, novel targets, and updates on preclinical candidates. Hear the groundbreaking work of Dr. Dennis Selkoe (Harvard) as the keynote address. Network with leaders in the field while learning the latest research.